Nearly $1 Billion Allocated for DePuy Hip Implant Recall Litigation
Johnson & Johnson has allocated a fund of $922 million for settlements and litigation battles they are facing due to the recalled DePuy ASR hip implants.The hip implants have had high failure rates and many patients have needed revision surgery because of the recalled products.There are reports that the company will have to pay out even more than what's allocated in the fund.
Johnson & Johnson has had several recall and litigation issues in the past few years, including quality control issues with a manufacturing plant in Pennsylvania.Last December, the company's CEO admitted to conducting a phantom recall in 2009 - instead of issuing a public recall, the company secretly sent contractors out to buy up the recalled products.
Some of the recalled products have included:
- Simponi (an arthritis injection device)
- Children's Motrin; Children's Tylenol
- Regular strength Tylenol
The recalled ASR hip implants have caused many complications for patients, including difficulty walking, pain or inflammation at hip replacement site, loosening or dislocation of implant, and bone fractures around the implant.There have also been reports of higher metal levels in the blood because of the defective implants.If you have questions about this hip recall, get informed through our DePuy information page.
Our firm currently represents patients with DePuy hip recallclaims and defective drug litigation.If you or a loved one have suffered because of this recall, you should contact a board certified recall attorney today.We can give you a free evaluation about your potential claim.You may call toll free (877) 342-2020, or (713) 523-0001.You may also fill out our online form.